483
Vanda Pharmaceuticals IncVanda Pharmaceuticals Inc – FDA 483, Mar 12, 2024
Record Details
Vanda Pharmaceuticals Inc. in Washington, DC, was issued a Form 483 following an inspection from March 4-12, 2024. The inspection revealed that the firm failed to notify the FDA of an investigator's termination from a study. Additionally, informed consent documents for a clinical study lacked disclosure of known allergic reaction risks to subjects, indicating deficiencies in sponsor oversight and subject protection.
View Company Profile
ID · 43444eed-9c8f-4ef6-98fe-0ea3af1fae29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.